Midcap Pharma Stock Fixes Record-Date For 37.5% Interim Dividend, Revenue Up 15% YoY

Natco Pharma Ltd., a midcap pharma stock announced a 2nd interim dividend of Rs. Rs. 0.75 per share. The stock has fixed the record date on November 22, 2022. The payment of said interim dividend will be paid from 30th November 2022.

The company informed the stock exchanges, "Board of Directors of the Company at their meeting held today have considered and declared 2nd interim dividend of Rs. 0.75 (seventy-five paise only i.e., 37.5%) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2022-23. The date for taking on record of its shareholders eligible for the purpose of payment of 2nd interim dividend i.e., the record date is fixed as Tuesday the 22nd day of November 2022."

According to the company's statement, its revenue gained 15% to Rs. 432 crore in Q2 FY23, as against Rs. 377 crore in Q2 FY22. Its net profit fell 13% to Rs. 57 crore, compared to Rs. 65 crore in Q2 FY22. On the other hand, in Q2 FY23 Ebitda gained 35% to Rs. 95 crore from Rs. 71 crore in Q2 FY22.

Stock performance

In the last 1 month, the company's share price fell by 1.19%, and in the past 6 months, its share price fell by 13.93%. However, in the long run its share price increased sharply from Rs. 158.44/share on November 14, 2013, to Rs. 583.50 in the second week of November, 2022. The 52-week high level of this stock is Rs. 944, and the 52-week low level of this stock is Rs. 575.35. The mid-cap company has a market capitalization of Rs. 10,661 crore.

Disclaimer

Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, and the author are not liable for any losses caused as a result of decisions based on the article. This article only incorporates recent stock-related information about the companies.